An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Better Therapeutics to Participate in Chardan’s Virtual Prescription Digital Therapeutics Summit
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Better Therapeutics, Inc. (NASDAQ: BTTX), a leader in prescription digital therapeutics, announced that CEO Kevin Appelbaum will participate in a fireside chat at Chardan's Virtual Prescription Digital Therapeutics Summit on April 11, 2022, at 1:30 p.m. ET. This event will focus on the company's innovative approach to nutritional cognitive behavioral therapy aimed at combating cardiometabolic diseases. A live webcast will be available for 90 days on their investor site.
Better Therapeutics aims to offer FDA-regulated, software-based solutions for conditions like type 2 diabetes and heart disease.
Positive
None.
Negative
None.
SAN FRANCISCO--(BUSINESS WIRE)--
Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced that Kevin Appelbaum, Co-Founder and CEO, will participate in a fireside chat at Chardan's Virtual Prescription Digital Therapeutics Summit on Monday, April 11, 2022 at 1:30 p.m. Eastern Time.
A live webcast will be available on the Presentations and Events section on the Better Therapeutics investor site for approximately 90 days after the event.
About Better Therapeutics
Better Therapeutics is a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The cognitive behavioral therapy delivered by Better Therapeutics’ PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics clinically validated mobile applications are intended to be prescribed by physicians and reimbursed like traditional medicines.
